Search results
Results from the WOW.Com Content Network
Chemotherapy: International Journal of Experimental and Clinical Chemotherapy is a peer-reviewed medical journal covering antimicrobial chemotherapy, published by Karger Publishers. The journal was established in 1960 and was originally named Chemotherapia , obtaining its current name in 1968.
It was established as Clinical Lymphoma in 2000, renamed to Clinical Lymphoma & Myeloma in 2005 and obtained its current name in 2010. The journal covers research on detection, diagnosis, prevention, and treatment of lymphoma, myeloma, leukemia, and related disorders, including macroglobulinemia, amyloidosis, and plasma-cell dyscrasias.
As of 2008, research in this area is active. [ 27 ] Another avenue for novel anti-cancer therapies is re-engineering some of the currently used conventional antibodies like trastuzumab (targeting HER2/neu ), cetuximab and panitumumab (both targeting the EGF receptor ), using the BiTE approach.
The use of rituximab has been established for the treatment of B-cell–derived hematologic malignancies, including follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL). [ 7 ] In addition to cure-directed treatment, people can benefit from self-care to manage symptoms.
In order to develop more effective first-line chemotherapy regimen for aggressive lymphomas, some researchers tried to add toposide to the standard [R]-CHOP regimen. [7] There were also attempts to further improve the efficacy of the [R]-CHOEP regimen with escalating the chemotherapy doses. This mode was called [R]-High-CHOEP. However, it did ...
EPOCH is an intensive chemotherapy regimen intended for treatment of aggressive non-Hodgkin's lymphoma. [1] [2] It is often combined with rituximab. In this case it is called R-EPOCH or EPOCH-R. The R-EPOCH regimen consists of: Rituximab: an anti-CD20 monoclonal antibody, which has the ability to kill B cells, be they normal or malignant;
The Journal of Immunology is a biweekly peer-reviewed medical journal that publishes basic and clinical studies in all aspects of immunology.Established in 1916, it changed its name to Journal of Immunology, Virus Research and Experimental Chemotherapy from 1943 to 1949, then returned to the original Journal of Immunology in 1950.
Cancer Chemotherapy and Pharmacology is a peer-reviewed medical journal covering oncological pharmacotherapy. It was established in 1978 and is published by Springer Science+Business Media . The editors-in-chief are Jan Hendrik Beumer ( University of Pittsburgh School of Pharmacy ) and Étienne Chatelut (Institut Claudius-Regaud).